Bacteria in the pathogenesis of inflammatory bowel disease.
about
A chaotic pore model of polypeptide antibiotic actionMucosal injuries due to ribosome-inactivating stress and the compensatory responses of the intestinal epithelial barrierCD209 in inflammatory bowel disease: a case-control study in the Spanish population.Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's diseaseMicrobial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis.Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.The central role of the gut microbiota in chronic inflammatory diseases.Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features.Nv-52: a novel thromboxane synthase inhibitor for the treatment of inflammatory bowel disease.Use of 16S rRNA Gene-Targeted Group-Specific Primers for Real-Time PCR Analysis of Predominant Bacteria in Mouse Feces.Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel diseaseMoxibustion inhibits interleukin-12 and tumor necrosis factor alpha and modulates intestinal flora in rat with ulcerative colitisVariable responses of formyl peptide receptor haplotypes toward bacterial peptides.Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend?Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage.Crohn's disease and the mycobacterioses: a quarter century later. Causation or simple association?The new prophylactic strategy for colon cancer in inflammatory bowel disease by modulating microbiota.The role of Escherichia coli in inflammatory bowel diseaseEffect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials.A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease.Lactic acid bacteria and bifidobacteria attenuate the proinflammatory response in intestinal epithelial cells induced by Salmonella enterica serovar Typhimurium.Brown rice and retrograded brown rice alleviate inflammatory response in dextran sulfate sodium (DSS)-induced colitis mice.Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohn's disease.New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system.Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease.
P2860
Q24647361-1A1A0CB7-BE85-47A7-8075-BEAE7271EFD0Q27027390-92B42E4D-583D-45FB-BD35-929B9914477CQ33309481-3190D9F5-F4A0-45FD-B1F7-EFDBD367D5C1Q33694932-E65A01A4-F08B-4998-8E34-1F65DD001052Q33842489-ABE16A55-9882-4CA1-91E0-3032C67DAF5AQ33860494-120A2BCE-9EB6-4639-966A-6233C9FDBDF1Q34305760-3DA17636-32D3-4021-8C3C-A63AF71D3BC3Q34410373-009C0E9A-4075-425F-A306-6339585B5FD9Q34654654-DB0190AC-DD99-4184-A7EA-9188FE3D8F74Q35696028-763BAC58-703A-4FB4-80EC-53CC4669BB2AQ35867599-4240BF8E-C171-485D-AAA3-E5C1C57B87FCQ36461032-EB6DC760-1774-4EBB-AB5D-963ECCB72FA5Q36732572-8BF1A117-F8FE-4A22-82DE-AEC3938BD745Q37082773-3C06C24A-235E-46BE-BF1B-B47A030B927EQ37094595-D58D18A4-C0CD-43E8-BB55-896712C1A261Q37724176-ECBDC257-1945-49FE-985F-D4422EE668E9Q37975540-80D70D59-0F19-43F1-BB17-6DB7F835D68CQ38068230-0E715FBB-E82F-4409-9F98-DFC5E7E3CEFCQ41947622-F5929683-EC6F-46FF-A477-1DBC2C373B7AQ43460878-59107607-CA51-4D0B-9D5F-DF11B576A067Q44693025-28665C42-9246-47AC-8EC5-E18C8FF69C4BQ45227059-E07C056C-3423-41EB-A40C-7F1FBFF6A1DCQ47576933-20ADDB89-B2BE-41E1-8446-57F68F9B0162Q50052663-F18AC9EB-D476-446F-8F8C-CF19C03D5768Q51545790-177D23F5-B57C-41B5-BCEF-6C9E93C87F27Q54412645-3252FDC6-558A-441A-8062-3069E8F71D07
P2860
Bacteria in the pathogenesis of inflammatory bowel disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Bacteria in the pathogenesis of inflammatory bowel disease.
@ast
Bacteria in the pathogenesis of inflammatory bowel disease.
@en
type
label
Bacteria in the pathogenesis of inflammatory bowel disease.
@ast
Bacteria in the pathogenesis of inflammatory bowel disease.
@en
prefLabel
Bacteria in the pathogenesis of inflammatory bowel disease.
@ast
Bacteria in the pathogenesis of inflammatory bowel disease.
@en
P1476
Bacteria in the pathogenesis of inflammatory bowel disease
@en
P2093
Jonathan Michael Rhodes
Sreedhar Subramanian
P304
P356
10.1097/01.QCO.0000244054.69253.F3
P577
2006-10-01T00:00:00Z